Ann: Medgate extends European ResAppDx trial, page-19

We all know this revolutionary technology works and is only way doctors can do remote consultation with confidence, hence.....

Dr Andy Fischer, CEO Medgate said: ‘’Our preliminary data is consistent with ResApp’s clinical study results and we received positive feedback from our patients regarding their experience with the ResAppDx test. We are extending the pilot to gain more experience and further optimise our workflows to maximise the benefits of ResAppDx for Medgate and its patients.‘’